We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Signs of life

11 Jan 2006 By Chris Hughes

The UK insurer seems to have tried and failed to do a $3bn deal with a US peer. But a rising share price will help it fund alternative buys. That s no bad thing. Aviva needs to diversify away from its lowgrowth home market and has a solid M&A record as both buyer and seller.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)